🇺🇸 Bovine thrombin in United States

17 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 17

Most-reported reactions

1. Coagulopathy — 4 reports (23.53%)
2. Venous Occlusion — 3 reports (17.65%)
3. Cranial Nerve Disorder — 2 reports (11.76%)
4. Haemothorax — 2 reports (11.76%)
5. Activated Partial Thromboplastin Time Prolonged — 1 report (5.88%)
6. Anti Factor V Antibody Positive — 1 report (5.88%)
7. Antibody Test Positive — 1 report (5.88%)
8. Circulatory Collapse — 1 report (5.88%)
9. Drug Dispensing Error — 1 report (5.88%)
10. Factor V Deficiency — 1 report (5.88%)

Source database →

Frequently asked questions

Is Bovine thrombin approved in United States?

Bovine thrombin does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Bovine thrombin in United States?

Instituto Grifols, S.A. is the originator. The local marketing authorisation holder may differ — check the official source linked above.